The focus on oral manifestations of dengue fever (DF) is not common in the scientific literature and the patient affected can present signs and symptoms that may not be noticed by dental professionals. This systematic review article was conducted to identify and discuss the oral manifestations related to DF. The electronic databases PubMed, Latin American and Caribbean Literature in Sciences (LILACS), Web of Science and Scopus were searched from November to December 2016 by two authors, simultaneously, using the search terms 'dengue and oral manifestation' combined. We included complete original articles, clinical trials and clinical case reports published in Portuguese, Spanish and English. No limits were applied to the year of publication. Review articles and those with no health outcomes were removed. A limited number of studies aimed to investigate the oral manifestations of DF (N = 25). However, several manifestations were identified in the oral cavity of patients diagnosed with DF such as acute gingival and palate bleeding, dryness of the mouth, taste changes, and erythematous plaque and vesicles on the tongue and palate. Osteonecrosis of jaw associated with DF was also reported. In conclusion, oral manifestations may represent a relevant contributory factor to identify DF disease among patients undergoing dental procedures in general practise.
INTRODUCTION
Dengue fever (DF) is an acute infectious disease of viral origin, in which the main vector is the female Aedes aegypti mosquito. [1] [2] [3] For more than 200 years, the dengue virus as well as its vector have been widely distributed in several tropical countries. 4 As a global disease, 5 it affects over 100 countries including the USA. 6 Due to its evolution in the last 50 years and the predominance in urban and semi-urban areas, DH has become an important public health problem. 7 It is estimated that approximately 2.5 billion people worldwide live in areas where the dengue virus can be transmitted. 8 Annually, 100 million cases of classical DH and 500 million cases of dengue haemorrhagic fever (DHF) are reported globally, with an average fatality rate of 5-20%. 9 The viral infection shows a variety of clinical presentations, so its accurate diagnosis is difficult and depends, in most cases, on laboratory tests. 10 Typical symptoms may include high fever, headache, back pain, muscle and joint pains (ankles, knees and shoulders), metallic taste in the mouth, loss of appetite, vomiting, diarrhoea, abdominal pain and rashes. 4, 11 The World Health Organization also mentions organ dysfunction as an indicator of the severity of dengue.
12.
The patient diagnosed with DH may present signs and symptoms of DH that may be overlooked by health professionals. 3 Thus, the present systematic literature review was conducted to identify the oral manifestations related or associated with DH disease as well as to discuss its clinical implications for general practitioners.
METHODS
For the purpose of this study, we followed instructions provided by Moher et al. 13 in 'Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement'. As instructed, we conducted '. . .a review of a clearly formulated question that uses systematic and explicit methods to identify, select, and critically appraise relevant research, and to collect and analyze data from the studies that are included in the review'.
Identification and selection of relevant research
An exploratory bibliographic search was conducted from October to December 2016 using the electronic databases PubMed, Latin American and Caribbean Literature in Sciences (LILACS), Web of Science and Scopus. Two authors performed the search employing the Medical Subject Heading (MeSH) term 'dengue' in combination with 'oral manifestation', 'dentistry', 'cutaneous', 'tongue', 'gingival bleeding', 'osteonecrosis' and 'mouth' (see Table 1 ). Inclusion criteria were original research articles, clinical trials and clinical case reports published in Portuguese, Spanish and English. No limits were applied to the year of publication.
Studies identified were exported to Mendeley software (London, UK) for Windows, and duplicates were removed. Subsequently, titles and abstracts were screened for relevance, considering the exclusion criteria. Next, the remaining studies were obtained in full text and were screened using the same criteria, the eligible ones being included in this review. We removed review studies, articles not available in full text and publications that did not address the oral manifestations of DH. Eligible studies also had their reference lists screened following the specified criteria with the ones eligible assigned to an additional category.
Data collection and analyses
All the selected articles addressed DH and its related oral manifestations and included the following parameters: authorship, year of publication, country of publication, type of study, sample size (and age), outcomes measured, relevant data and results, and study considerations.
Based on the studies' findings, we determined the following themes for critical analysis of the results: characteristics of the studies, oral manifestations related to DH and implications for practise. Yet, considering our study design and its referred findings, we present the section 'Study limitations'.
RESULTS AND DISCUSSION
For this systematic review, the initial search yielded a total of 750 titles found in the electronic search in the databases PubMed, LILACS, Web of Science and Scopus. Seventy-five studies were excluded for duplication and the remaining 675 papers were screened for relevance to this study. Six hundred and thirty publications were excluded after reading their titles and abstracts. Then, the 45 remaining documents were obtained in full text and assessed for eligibility, in consideration of oral manifestations of DH. After reading the documents in full text, 23 studies were included. Two additional studies that did not come up on the database search were also included, totalizing 25 studies eligible for this systematic review (see Fig. 1 and Table 2 ). No studies from reference lists were added for not being eligible.
Characteristics of the studies
We identified 25 studies that addressed, in some respect, the oral manifestations of DH. Out of the 25 documents selected, 40% (N = 10) were clinical case (continued) A few studies, basically clinical case reports, addressed, in a specific way, oral manifestations associated with or related to DH such as lingual haematoma, 14 thrombocytopaenic disorders, 15, 16 post-extraction bleeding, 17 gingival bleeding, 18, 19 osteonecrosis of the jaw 20 and dentoalveolar bone. 21 Blisters in different areas of the mouth and difficulty in swallowing were also reported. 22,23. Other research studies addressed haemorrhagic manifestations, 24 dermatological (cutaneous or mucocutaneous) manifestations 7, 25, 26 and clinical, laboratorial and epidemiological characteristics of DH.
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Oral manifestations related to DH
The search revealed a small number of studies in the literature reporting oral manifestations of DH disease Clinical and laboratory signs History of GB in physical examination were frequent in severe dengue disease (P < 0.01)
Bleeding, severe haemorrhage, hemoconcentration and thrombocytopenia did not reach adequate diagnostic accuracy BM = bleeding manifestations; CC = confirmed cases of dengue; CI = confidence interval; COMD = cutaneous oral manifestations of dengue; CST = clinical and serological tests; DF = dengue fever; DHF = dengue haemorrhagic fever; DSS = dengue shock syndrome; GB = gingival bleeding; HM = haemorrhagic manifestations; OC = oral candidiasis; OM = oral manifestations; OMC = oral mucous membrane; OR = odds ratio.
(research studies and clinical cases). Sample sizes found in most studies were acceptable. Table 2 presents the main findings of all of the 25 selected articles that addressed DH and its related or associated oral manifestations and included the following parameters: authorship, year of publication, country of publication, type of study, sample size (and age), outcomes measured, relevant data and results, and study considerations. Oral manifestations are infrequently observed in cases of classic DH being more commonly associated with DHF, in which gingival bleeding erythema, lip crusts, and vesicles on the lips and palate are the prominent oral characteristics in dengue virus infection. 2, 7, 15, 16, 18, 19, 22, 25, 27 Oral candidiasis, 26, 32 osteonecrosis of the dentoalveolar structure 20, 21 and post-extraction bleeding 17 were also reported.
We observed in the clinical case reports raised in this systematic literature review [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] that several patients presented poor oral hygiene and presence of dental biofilm and calculus. In light of these published reports, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] in which the main signs were bleeding of the tongue, palate and gingiva, as well as vesicles on the lips and palate, and the research studies, 1, 2, 7, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] that showed that the occurrence of oral manifestations varies greatly among hospitalized patients, we hypothesized that associated systemic diseases and/or previous poor oral health may be a contributory factor to the presentation of the bleeding conditions observed. In other words, among others, the occurrence of associated comorbidities and/or the presence of dental biofilm or calculus on the tooth surfaces could have led, synergistically, to the oral manifestation of DH in some of the reported cases.
Yet, although oral manifestations regarding DH are not commonly reported in the scientific literature, dengue viral infection presents a broad range of alterations and dental professionals must be aware of this. 16 This systematic literature review highlights the importance of oral lesions or presentations of DH to clinicians of all fields, especially in dengue endemic areas. Thus, a detailed description of oral changes in the context of dengue infections is lacking in the scientific literature, requiring future research with appropriate methodologies focusing on the oral manifestations of DH.
Implications for practise
Given the high complexity of the nature of dengue and failures in control strategies, there is a need to find ways to reduce the morbidity and mortality attributed to this condition, 27 because its adequate identification allows the prompt institution of treatment and prevention of more severe complications. 15 Dengue monitoring is still a challenge due mainly to the late diagnosis of the disease and its eventual evolution into an epidemic. 25 The identification of oral manifestations of dengue is a relevant and contributory factor in establishing the early diagnosis of this pathology, because the oral cavity is considered the gateway and the place of manifestation of a wide variety of systemic diseases. In this sense, we highlight the role of dental professionals, especially general practitioners, in identifying these problems and guiding the patient regarding the search for medical care, aiming at the definitive diagnosis, as well as the effective treatment of the disease.
Because haemorrhage is the hallmark of this disease, it is imperative that dental practitioners are made aware of the implications of performing dental procedures in a patient suffering from DF/DHF. The importance of taking a good pretreatment history cannot be overemphasized. 17 It is important to take a correct medical history along with proper diagnosis in episodes of acute gingival bleeding as the dentist is the first person who can actually diagnose and refer these patients for proper management. 19 Moreover, if a patient comes for dental care and presents signs or symptoms of the disease, their care should be delayed, or it is especially important to not perform more invasive procedures due to the risk of haemorrhagic complications. In addition, medicines have to be carefully prescribed given the nature of the disease. Patients suspected of dengue are not recommended to use non-essential drugs, especially anti-inflammatories, antibiotics and other drugs that show renal, hepatic or haematological toxicity. 
